Toothsi parent MakeO raises Rs 90 crore led by Singularity AMC to expand in India, Southeast Asia

Toothsi’s parent company, MakeO, secures ₹90 crore in funding led by Singularity AMC to expand its clinics, enhance manufacturing capabilities, and grow throughout Southeast Asia.

Related: Enterprise AI startup Ema raises $77 million in Series B funding led by Creaegis

MakeO, the parent firm of clear aligner brand Toothsi, has secured ₹90 crore in a funding round led by Singularity AMC. DSP Family Office, Genesis and Unispace Ventures also participated. The company intends to use the new capital to expand its dental care operations throughout India and Southeast Asia.

The funding arrives as MakeO reinforces its standing in the expanding dental technology market. Its approach brings together digital dental services, physical clinical centres, advanced manufacturing and technology-driven treatment planning.

In addition, the company is exploring growth beyond organic expansion. It is also considering acquisitions of dental clinic chains and clear aligner companies to broaden its presence across both regions.

The latest fundraising follows MakeO’s acquisition of Singapore-based dental care firm Zenyum. Taken together, these developments underscore the company’s goal of creating a more extensive dental care platform across Asia.

MakeO intends to distribute the newly raised capital among several areas of its business. These investments will enable the company to enhance customer experience, broaden its clinical network, and reinforce its manufacturing capabilities.

1. Broaden Offline Clinics Throughout India and Southeast Asia

MakeO plans to expand its offline footprint across both existing and new markets. In-person clinics can give customers access to consultations, treatment planning, and follow-up care.

The company is also considering acquisitions of dental clinic chains and aligner companies. This strategy could speed up expansion by bringing in established clinics, regional expertise, and customer networks.

2. Enhance Manufacturing Capabilities

MakeO runs an integrated clear aligner manufacturing facility in the Mumbai Metropolitan Region. The facility reinforces the company’s commitment to developing and producing dental products for its markets.

The new investment is expected to enhance manufacturing operations and support the company’s regional growth plans. Additionally, enhanced production capabilities may help the company manage demand as its customer base grows.

3. Invest in Technology and the Customer Experience

Technology represents another key element of MakeO’s strategy. The company is building a digital-first dental platform that integrates treatment planning, clinical services, and manufacturing.

These technology investments are expected to strengthen backend operations and enhance the customer journey. Moreover, digital tools can facilitate treatment planning and communication among customers, dentists, and clinical teams.

MakeO was founded in 2018 and initially created Toothsi, a brand specializing in clear aligners and teeth-straightening solutions. It subsequently broadened its services beyond dental care.

In 2022, the company placed Toothsi and Skinnsi under the MakeO umbrella. This transition enabled it to develop a wider consumer platform providing dental, skin and hair care services.

Clear aligners are transparent dental devices that gradually shift teeth under professional supervision. For certain orthodontic cases, they have emerged as an alternative to traditional braces.

MakeO’s business model integrates digital customer acquisition, clinical support and in-house manufacturing. This setup enables the company to connect customers with dental professionals while retaining control over key aspects of the treatment process.

Consequently, MakeO is positioning itself as more than a single-product brand. Its goal is to create an integrated consumer dental technology platform.

A major milestone in MakeO’s expansion strategy is its acquisition of Singapore-based Zenyum.

Zenyum operates within the dental care and clear aligner sectors. The acquisition has enabled MakeO to expand its presence throughout Southeast Asia and other Asian markets.

After the integration, the group has approximately 1,100 partner dentists across 10 countries. This network provides the company with a broader regional platform for delivering dental care services.

Why Does Southeast Asia Matter to MakeO?

Expanding into Southeast Asia would allow MakeO to reach markets beyond India. It could also leverage the regional presence and customer relationships developed through Zenyum.

However, expanding internationally involves more than entering additional countries. The company needs to respond to local customer needs, regulatory standards, and variations in healthcare delivery.

By combining its manufacturing capabilities with a wider dental network, MakeO seeks to establish a more integrated regional business.

The latest funding could help advance this strategy by strengthening infrastructure, integrating operations, and expanding its physical presence across target markets.

MakeO’s expansion plans follow the company’s report of strong business performance. According to company disclosures reported by Business Standard and other publications, its combined business has surpassed ₹500 crore in revenue and reached EBITDA profitability earlier in 2026.

EBITDA, meaning earnings before interest, taxes, depreciation and amortisation, is a commonly used measure of operating performance. Reaching EBITDA profitability may indicate that a business is generating sufficient operating income to cover its operating costs before accounting for these items.

For a consumer healthcare company, this milestone is especially significant because expansion requires investment in clinics, technology, manufacturing and customer support.

MakeO has also established an ambitious objective: the company plans to double its revenue within the next two to three years.

Achieving that objective will require expanding its customer base, enhancing operational efficiency and successfully integrating its acquisitions. The new funding offers additional resources, but reaching the target will depend on execution and market demand.

MakeO’s approach brings together multiple components that may contribute to sustainable growth.

• Digital-first services: Digital platforms can make it easier for customers to access consultations and plan their treatments.
• In-house manufacturing: Increased production control can support the company in managing product quality and capacity.
• Physical clinical centres: Clinics offer opportunities for consultations, treatment assistance and follow-up care.
• Strategic acquisitions: Acquisitions may enable MakeO to enter new markets and grow its network more quickly.
• Regional expansion: Operating across India and Southeast Asia can help diversify its customer base.

Together, these elements form an integrated business model. Rather than depending solely on online sales, MakeO is investing in the infrastructure required to support customers throughout their treatment journey.

Nevertheless, as its operations expand, the company will need to preserve service quality and control expansion costs.

MakeO’s ₹90 crore fundraising round underscores ongoing investor interest in consumer healthcare and technology-driven dental services.

Digital platforms have opened up new ways for customers to find dental treatments and connect with professionals. Meanwhile, manufacturing technology and clinical networks continue to be crucial for providing treatment safely and consistently.

MakeO’s model brings these areas together by incorporating consumer brands, manufacturing facilities, technology and partner dentists.

The investment could also stimulate additional activity in the dental technology sector, especially among companies seeking to integrate online services with offline care.

However, long-term growth will rely on affordability, clinical standards, customer trust and the capacity to provide consistent experiences across different markets.

Backed by new funding from Singularity AMC and other investors, MakeO is getting ready for its next phase of expansion. The company intends to reinforce its manufacturing and technology infrastructure while expanding its clinical presence across India and Southeast Asia.

The acquisition of Zenyum has already expanded its footprint throughout the region. At the same time, its emphasis on possible acquisitions may enable it to enter more markets and broaden access to dental services.

The company’s aim to double revenue within the next two to three years provides a clear growth objective. Achieving this goal will require MakeO to integrate its businesses efficiently, grow its network and preserve operational profitability.

Overall, MakeO’s ₹90 crore funding round represents a significant milestone in its pursuit of building a larger dental technology platform across Asia. Its progress will hinge on how effectively it transforms the new capital into customer growth, stronger operations and sustainable business performance.